Effect of edaravone, a novel free radical scavenger, on endothelium-dependent vasodilation in smokers - 26/08/11
Résumé |
The forearm blood flow (FBF) responses to acetylcholine and to sodium nitroprusside were evaluated before and after administration of edaravone in 10 smokers and 10 nonsmokers. FBF response to acetylcholine was lower in smokers than in nonsmokers. The vasodilatory effects of sodium nitroprusside were similar in both groups. Co-infusion of edaravone increased the FBF response to acetylcholine in smokers, but did not affect the FBF response to acetylcholine in nonsmokers. The administration of NG-monomethyl-l-arginine abolished edaravone-induced augmentation of the FBF response to acetylcholine in smokers. The antioxidative agent edaravone increases nitric oxide mediated vasodilation through a decrease in oxidative stress.
Le texte complet de cet article est disponible en PDF. This study was supported in part by grants-in-aid 1559075100 and KOSEI151201 for scientific research from the Ministry of Education, Science and Culture of Japan, Tokyo, Japan. |
Vol 94 - N° 8
P. 1070-1073 - octobre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?